388 related articles for article (PubMed ID: 16264338)
1. Towards immunotherapy for peanut allergy.
Pons L; Palmer K; Burks W
Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):558-62. PubMed ID: 16264338
[TBL] [Abstract][Full Text] [Related]
2. Current Trend in Immunotherapy for Peanut Allergy.
Joo Chan C; Richardo T; Lim RLH
Int Rev Immunol; 2018; 37(6):279-290. PubMed ID: 30638084
[TBL] [Abstract][Full Text] [Related]
3. Beyond allergen avoidance: update on developing therapies for peanut allergy.
Li XM
Curr Opin Allergy Clin Immunol; 2005 Jun; 5(3):287-92. PubMed ID: 15864090
[TBL] [Abstract][Full Text] [Related]
4. New approaches for treatment of peanut allergy: chances for a cure.
Burks W; Lehrer SB; Bannon GA
Clin Rev Allergy Immunol; 2004 Dec; 27(3):191-6. PubMed ID: 15630155
[TBL] [Abstract][Full Text] [Related]
5. Peanut allergenicity.
Scurlock AM; Burks AW
Ann Allergy Asthma Immunol; 2004 Nov; 93(5 Suppl 3):S12-8. PubMed ID: 15562869
[TBL] [Abstract][Full Text] [Related]
6. Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy.
Srivastava KD; Siefert A; Fahmy TM; Caplan MJ; Li XM; Sampson HA
J Allergy Clin Immunol; 2016 Aug; 138(2):536-543.e4. PubMed ID: 27130858
[TBL] [Abstract][Full Text] [Related]
7. Immunologic and clinical responses to parenteral immunotherapy in peanut anaphylaxis--a study using IgE and IgG4 immunoblot monitoring.
Bullock RJ; Barnett D; Howden ME
Allergol Immunopathol (Madr); 2005; 33(5):250-6. PubMed ID: 16287543
[TBL] [Abstract][Full Text] [Related]
8. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
[TBL] [Abstract][Full Text] [Related]
9. Anti-hIgE gene therapy of peanut-induced anaphylaxis in a humanized murine model of peanut allergy.
Pagovich OE; Wang B; Chiuchiolo MJ; Kaminsky SM; Sondhi D; Jose CL; Price CC; Brooks SF; Mezey JG; Crystal RG
J Allergy Clin Immunol; 2016 Dec; 138(6):1652-1662.e7. PubMed ID: 27372563
[TBL] [Abstract][Full Text] [Related]
10. The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions.
Gomez F; Bogas G; Gonzalez M; Campo P; Salas M; Diaz-Perales A; Rodriguez MJ; Prieto A; Barber D; Blanca M; Torres MJ; Mayorga C
Clin Exp Allergy; 2017 Mar; 47(3):339-350. PubMed ID: 28160513
[TBL] [Abstract][Full Text] [Related]
11. Current and emerging immunotherapeutic approaches to treat and prevent peanut allergy.
Miller DS; Brown MP; Howley PM; Hayball JD
Expert Rev Vaccines; 2012 Dec; 11(12):1471-81. PubMed ID: 23252390
[TBL] [Abstract][Full Text] [Related]
12. Current developments in peanut allergy.
Palmer K; Burks W
Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):202-6. PubMed ID: 16670515
[TBL] [Abstract][Full Text] [Related]
13. Peanut Allergy: New Developments and Clinical Implications.
Commins SP; Kim EH; Orgel K; Kulis M
Curr Allergy Asthma Rep; 2016 May; 16(5):35. PubMed ID: 27039393
[TBL] [Abstract][Full Text] [Related]
14. [Peanut allergy].
Turcanu V
Pneumologia; 2010; 59(2):77-82. PubMed ID: 20695362
[TBL] [Abstract][Full Text] [Related]
15. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
Hourihane JO; Allen KJ; Shreffler WG; Dunngalvin G; Nordlee JA; Zurzolo GA; Dunngalvin A; Gurrin LC; Baumert JL; Taylor SL
J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
[TBL] [Abstract][Full Text] [Related]
16. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.
Li XM; Serebrisky D; Lee SY; Huang CK; Bardina L; Schofield BH; Stanley JS; Burks AW; Bannon GA; Sampson HA
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):150-8. PubMed ID: 10887318
[TBL] [Abstract][Full Text] [Related]
17. The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy.
de Leon MP; Rolland JM; O'Hehir RE
Expert Rev Mol Med; 2007 Jan; 9(1):1-18. PubMed ID: 17210088
[TBL] [Abstract][Full Text] [Related]
18. Strategies to mitigate peanut allergy: production, processing, utilization, and immunotherapy considerations.
White BL; Shi X; Burk CM; Kulis M; Burks AW; Sanders TH; Davis JP
Annu Rev Food Sci Technol; 2014; 5():155-76. PubMed ID: 24387606
[TBL] [Abstract][Full Text] [Related]
19. Developing therapies for peanut allergy.
Bublin M; Breiteneder H
Int Arch Allergy Immunol; 2014; 165(3):179-94. PubMed ID: 25531161
[TBL] [Abstract][Full Text] [Related]
20. Food allergies and hypersensitivity: a review of pharmacotherapy and therapeutic strategies.
Burks W; Kulis M; Pons L
Expert Opin Pharmacother; 2008 May; 9(7):1145-52. PubMed ID: 18422472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
